$3.24-0.06 (-1.82%)
Exicure, Inc.
Exicure, Inc. in the Healthcare sector is trading at $3.24. The stock is currently near its 52-week low of $3.10, remaining 34.3% below its 200-day moving average. Technical signals show oversold RSI of 25 and bearish MACD signal, explaining why XCUR maintains its current current market pressure. The Whystock Score of 45/100 suggests a balanced risk-reward profile.
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Exicure, Inc. does not have significant operations. Previously, the company focused on developing of nucleic acid therapies targeting ribonucleic acid against validated targets. Exicure, Inc. was founded in 2011 and is headquartered in Redwood City, ...